{"id":"https://openalex.org/W4205106981","doi":"https://doi.org/10.1177/10781552221074025","title":"Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia","display_name":"Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia","publication_year":2022,"publication_date":"2022-01-21","ids":{"openalex":"https://openalex.org/W4205106981","doi":"https://doi.org/10.1177/10781552221074025","pmid":"https://pubmed.ncbi.nlm.nih.gov/35060786"},"language":"en","primary_location":{"id":"doi:10.1177/10781552221074025","doi":"https://doi.org/10.1177/10781552221074025","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10781552221074025","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4205106981"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066396243","display_name":"Arsia Jamali","orcid":"https://orcid.org/0000-0002-8488-8312","observed_orcids":["https://orcid.org/0000-0002-8488-8312","https://orcid.org/0000-0002-5582-4547"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arsia Jamali","raw_affiliation_strings":["Eisenhower Health","Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-8488-8312","affiliations":[{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002823886","display_name":"Khashayar Nemovi","orcid":"https://orcid.org/0000-0002-9436-626X","observed_orcids":["https://orcid.org/0000-0002-9436-626X"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khashayar Nemovi","raw_affiliation_strings":["Eisenhower Health","Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062380029","display_name":"Jaspreet Kaur","orcid":"https://orcid.org/0000-0002-4125-5355","observed_orcids":["https://orcid.org/0000-0002-4125-5355"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaspreet Kaur","raw_affiliation_strings":["Eisenhower Health","Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-4125-5355","affiliations":[{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001190634","display_name":"Constantin A Dasanu","orcid":"https://orcid.org/0000-0003-0425-8394","observed_orcids":["https://orcid.org/0000-0003-0425-8394"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constantin A Dasanu","raw_affiliation_strings":["Department of Medical Oncology and Hematology, University of California in San Diego Health System, San Diego, CA, USA","Eisenhower Health","Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0425-8394","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Hematology, University of California in San Diego Health System, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.1777,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.41189874,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"28","issue":"5","first_page":"1218","last_page":"1221"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03269999846816063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.026799999177455902,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/monoclonal-b-cell-lymphocytosis","display_name":"monoclonal B-cell lymphocytosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5929999947547913},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8169999718666077},{"id":"https://openalex.org/keywords/b-cell-dysregulation","display_name":"B cell dysregulation","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-induced-lymphoproliferative-disorder","display_name":"drug-induced lymphoproliferative disorder","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9578894972801208},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9212988615036011},{"id":"https://openalex.org/C2780126324","wikidata":"https://www.wikidata.org/wiki/Q612345","display_name":"Lymphocytosis","level":2,"score":0.8417890071868896},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8287334442138672},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5775763392448425},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5031372904777527},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.49312373995780945},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.48979878425598145},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45936766266822815},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4394882023334503},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.43707555532455444},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4162621796131134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3933982253074646},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.35160213708877563},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3296445608139038},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32895371317863464},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.22166001796722412}],"mesh":[{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000096142","descriptor_name":"Cutaneous Malignant Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008218","descriptor_name":"Lymphocytosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008218","descriptor_name":"Lymphocytosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008218","descriptor_name":"Lymphocytosis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/10781552221074025","doi":"https://doi.org/10.1177/10781552221074025","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10781552221074025","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:35060786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35060786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1975992327","https://openalex.org/W2067978628","https://openalex.org/W2131640081","https://openalex.org/W2287821501","https://openalex.org/W2590359520","https://openalex.org/W2606528598","https://openalex.org/W2766565264","https://openalex.org/W2797410539","https://openalex.org/W2920949246","https://openalex.org/W2971864336","https://openalex.org/W3082731516"],"related_works":["https://openalex.org/W4401648809","https://openalex.org/W4213458427","https://openalex.org/W4367333228","https://openalex.org/W2528236085","https://openalex.org/W2270117727","https://openalex.org/W2513916848","https://openalex.org/W3203307707","https://openalex.org/W2593339730","https://openalex.org/W4307042591","https://openalex.org/W2621187672"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Immune":[1],"checkpoint":[2],"inhibitors,":[3],"such":[4],"as":[5],"programmed":[6],"death":[7],"(PD)-1":[8],"inhibitor":[9],"nivolumab,":[10,65],"are":[11],"currently":[12,86],"widely":[13],"used":[14],"in":[15,90,97],"treatment":[16,57],"of":[17,43,64,104],"various":[18],"malignancies.":[19,123],"Due":[20],"to":[21,31,75],"their":[22],"widespread":[23],"application,":[24],"any":[25],"new":[26],"potential":[27,117],"adverse":[28],"effects":[29],"due":[30],"these":[32],"agents":[33],"necessitate":[34],"careful":[35],"assessment.":[36],"CASE":[37],"REPORT:":[38],"We":[39],"report":[40],"a":[41,54],"case":[42],"an":[44],"81-year-old":[45],"man":[46],"with":[47,58],"recurrent":[48],"high-risk":[49],"malignant":[50],"melanoma":[51,95],"who":[52],"underwent":[53],"12-month":[55],"adjuvant":[56],"nivolumab.":[59],"Shortly":[60],"after":[61],"the":[62,101],"course":[63],"he":[66],"developed":[67],"monoclonal":[68],"B-cell":[69,107,122],"lymphocytosis":[70],"(MBL)":[71],"which":[72],"subsequently":[73],"progressed":[74],"chronic":[76],"lymphocytic":[77],"leukemia":[78],"(CLL).":[79],"MANAGEMENT":[80],"AND":[81],"OUTCOME:":[82],"The":[83],"patient":[84],"is":[85],"doing":[87],"clinically":[88],"well":[89],"Rai":[91],"stage":[92],"0.":[93],"Malignant":[94],"remains":[96],"remission.":[98],"CONCLUSION:":[99],"Considering":[100],"pathophysiologic":[102],"plausibility":[103],"nivolumab":[105,120],"inducing":[106],"dysregulation":[108],"via":[109],"PD-1":[110],"inhibition,":[111],"we":[112],"suggest":[113],"further":[114],"studies":[115],"on":[116],"association":[118],"between":[119],"and":[121]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-01-26T00:00:00"}